Singapore markets closed
Straits Times Index
3,290.70 +24.75 (+0.76%) Nikkei
38,229.11 +155.13 (+0.41%) Hang Seng
18,963.68 +425.87 (+2.30%) FTSE 100
8,433.76 +52.41 (+0.63%) Bitcoin USD
60,730.55 -2,281.57 (-3.62%) CMC Crypto 200
1,261.13 -96.88 (-7.13%)
Atreca, Inc. (BCEL)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 03:53PM EDT
| Previous close | 0.0930 |
| Open | 0.0901 |
| Bid | 0.2100 x 800 |
| Ask | 0.2050 x 800 |
| Day's range | 0.0901 - 0.0985 |
| 52-week range | 0.0520 - 1.2640 |
| Volume | |
| Avg. volume | 512,480 |
| Market cap | 3.573M |
| Beta (5Y monthly) | 1.02 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Atreca (BCEL) Suspends Lead Drug Evaluation, Stock Falls 37%
Atreca (BCEL) suspends the development of only pipeline candidate, ATRC-101, in clinical evaluation, as part of its business restructuring efforts and cuts headcount by 40%. The stock falls 37%.
© 2024 Yahoo. All rights reserved.